Detalhe da pesquisa
1.
Salvage Surgery for Initially Unresectable HCC With PVTT Converted by Locoregional Treatment Plus Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody.
Oncologist
; 2024 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38478404
2.
An inferior vena cava-priority approach in laparoscopic isolated hepatic caudate lobectomy.
Langenbecks Arch Surg
; 409(1): 106, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38556526
3.
A new scoring system for predicting the outcome of hepatocellular carcinoma patients without microvascular invasion-a large-scale multicentre study.
HPB (Oxford)
; 26(6): 741-752, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38472016
4.
Combination of alpha-fetoprotein and neutrophil-to-lymphocyte ratio to predict treatment response and survival outcomes of patients with unresectable hepatocellular carcinoma treated with immune checkpoint inhibitors.
BMC Cancer
; 23(1): 547, 2023 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37322411
5.
Overall survival of patients with hepatocellular carcinoma treated with sintilimab and disease outcome after treatment discontinuation.
BMC Cancer
; 23(1): 1017, 2023 Oct 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37867191
6.
Gemcitabine and cisplatin or oxaliplatin chemotherapy combined with atezolizumab plus bevacizumab for advanced biliary tract cancers: a single-arm trial.
Future Oncol
; 19(15): 1029-1035, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37132469
7.
Chromatin remodeling factor ARID2 suppresses hepatocellular carcinoma metastasis via DNMT1-Snail axis.
Proc Natl Acad Sci U S A
; 117(9): 4770-4780, 2020 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32071245
8.
DCAF13 promotes breast cancer cell proliferation by ubiquitin inhibiting PERP expression.
Cancer Sci
; 113(5): 1587-1600, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35178836
9.
Impact of Bile Duct Tumor Thrombus on the Long-Term Surgical Outcomes of Hepatocellular Carcinoma Patients: A Propensity Score Matching Analysis.
Ann Surg Oncol
; 29(2): 949-958, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34591226
10.
Hazard rate for postoperative recurrence in patients with hepatocellular carcinoma at Barcelona Clinic Liver Cancer stage 0 or A1: A multicenter observational study.
Hepatol Res
; 52(11): 947-956, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35839151
11.
Transarterial chemoembolization plus a PD-1 inhibitor with or without lenvatinib for intermediate-stage hepatocellular carcinoma.
Hepatol Res
; 52(8): 721-729, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35536197
12.
Developmental artificial neural network model to evaluate the preoperative safe limit of future liver remnant volume for HCC combined with clinically significant portal hypertension.
Future Oncol
; 18(21): 2683-2694, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35699041
13.
Transcatheter arterial chemoembolization plus atezolizumab and bevacizumab for unresectable hepatocellular carcinoma: a single-arm, phase II trial.
Future Oncol
; 18(30): 3367-3375, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35968836
14.
Postoperative adjuvant transarterial chemoembolization improves outcomes of hepatocellular carcinoma associated with bile duct tumor thrombus: a propensity score matching analysis.
HPB (Oxford)
; 24(4): 547-557, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34635434
15.
Recurrence hazard rate in patients with hepatocellular carcinoma and bile duct tumor thrombus: a multicenter observational study.
HPB (Oxford)
; 24(10): 1703-1710, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35523655
16.
Patterns, treatments, and prognosis of tumor recurrence after resection for hepatocellular carcinoma with microvascular invasion: a multicenter study from China.
HPB (Oxford)
; 24(7): 1063-1073, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34961677
17.
Long-Term Outcomes of Anatomic Versus Nonanatomic Resection in Hepatocellular Carcinoma Patients with Bile Duct Tumor Thrombus: A Propensity Score Matching Analysis.
Ann Surg Oncol
; 28(12): 7686-7695, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33929619
18.
A nomogram based on combining systemic and hepatic inflammation markers for predicting microscopic bile duct tumour thrombus in hepatocellular carcinoma.
BMC Cancer
; 21(1): 272, 2021 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33711965
19.
An Eastern Hepatobiliary Surgery Hospital/Portal Vein Tumor Thrombus Scoring System as an Aid to Decision Making on Hepatectomy for Hepatocellular Carcinoma Patients With Portal Vein Tumor Thrombus: A Multicenter Study.
Hepatology
; 69(5): 2076-2090, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30586158
20.
Nomogram for prediction of the international study Group of Liver Surgery (ISGLS) grade B/C Posthepatectomy liver failure in HBV-related hepatocellular carcinoma patients: an external validation and prospective application study.
BMC Cancer
; 20(1): 1036, 2020 Oct 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33115425